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tion, and stroke).
RESULTS A total of 768 procedures from 597 patients were included
in the analysis, with DM comprising 52.9% of the sample. Diabetics
had higher rate of concomitant hypertension (97.8% vs. 86.4%;
p<0.0001), hyperlipidemia (93.3% vs. 81.1%; p<0.0001), coronary ar-
tery disease (75.9% vs. 58.0%; p<0.0001), heart failure (24.6% vs.
14.4%; p¼0.001), and chronic kidney disease (26.4% vs. 6.6%;
p<0.0001) compared to non-diabetics. Mean Rutherford category was
signiﬁcantly higher for diabetics (3.50.9 vs. 3.10.7; p<0.0001) with
higher rates of presenting critical limb ischemia (30.8% vs. 15.6%;
p<0.0001). Although patients with DM had higher rates of heavily
calciﬁed lesions (64.3% vs. 55.5%; p¼0.01), incidence of chronic total
occlusion was lower (58.6% vs. 71.8%; p¼0.001). Kaplan-Meier sur-
vival analysis evidenced signiﬁcantly higher MACE in DM (13.9% vs.
5.7%; p¼0.003) as well as MALE (37.7% vs. 28.0%; p¼0.024) at 12-
months. After adjusting for signiﬁcant differences in baseline and
lesion characteristics, patients with DM were not at a signiﬁcantly
higher risk for experiencing MACE (hazard ratio or HR¼1.60; 95%
conﬁdence interval or CI¼0.80-3.33; p¼0.19; Figure 1A) and MALE
(HR¼1.28; 95% CI¼0.93-1.78; p¼0.14; Figure 1B).CONCLUSIONS Contemporary endovascular treatment of femo-
ropopliteal PAD with stents in patients with DM is associated with
similar limb and cardiovascular outcomes as those without DM,
despite more adverse co-morbid factors and lesion characteristics.
CATEGORIES ENDOVASCULAR: Peripheral Vascular Disease and
Intervention
KEYWORDS Diabetes mellitus, Peripheral vascular intervention
TCT-790
Safety and Effectiveness of the Nav-6 Filter in Preventing Distal
Embolization during JetStream Atherectomy of Infrainguinal Peripheral
Artery Lesions
Avantika Banerjee,1 Karan Sarode,2 Atif Mohammad,2
Emmanouil Brilakis,3 Gail A. Shammas,4 Nicolas W. Shammas4
1VA North Texas Health Care System, Dallas, TX; 2Dallas VA Medical
Center, Dallas, TX; 3VA North Texas Healthcare System and UT
Southwestern Medical Center, Dallas, TX; 4Midwest Cardiovascular
Research Foundation, Davenport, IA
BACKGROUND The risk of distal embolization (DE) during infrain-
guinal peripheral artery interventions (PAI) is often mitigated with the
use of embolic protection devices. There is limited data on the use of
ﬁlters with the Jetstream (JS) atherectomy device, a rotational cutter
with aspiration capacity. The Nav-6 ﬁlter is uniquely suited for use
with JS due to its wire compatibility and detachment from the ﬁlter,
however this off-label use of the ﬁlter has never been reported.
METHODS Consecutive patients between October 2008 and April 2015
undergoing endovascular infrainguinal PAI with JS were analyzed as
part of the Excellence in Peripheral Artery Disease (XLPAD) registry
(NCT01904851). Patients were divided into 2 subgroups with Nav-6
ﬁlter use vs no ﬁlter use. Descriptive and univariate analysis were
performed.RESULTS 141 patients (mean age 67.810.8 years; 169 lesions) were
included in this study. Nav-6 ﬁlter was used in 82 patients (59%).
Use of a ﬁlter was more frequent for longer lesions (146106 mm vs.
9172 mm; p¼0.006), severe stenosis (95% vs 87%, p¼0.04) and
chronic total occlusion (CTO; 33% vs. 8.3%; p¼0.002). Patients
receiving ﬁlters had longer procedure duration (10251 vs 6641 min)
with higher ﬂuoroscopy times (3116 vs 2110, p<0.001). Use of the
Nav-6 ﬁlter with the JS during PAI was associated with numerically
lower rates of DE (1.8% vs. 8% respectively; p¼0.1). Death and
amputation rates were low and similar in both groups. 12-month
target lesion revascularization rate was higher in the ﬁlter group (22%
vs. 2.7%; 0.02), likely secondary to the more complex lesions treated.
CONCLUSIONS The off-label use of the Nav-6 ﬁlter during JS athe-
rectomy was predominantly used during complex infrainguinal PAI
and was associated with numerically lower number of DE.
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BACKGROUND Although previous studies have reported that the
drug-eluting stent (DES) successfully reduced in-stent restenosis (ISR)
by inhibiting neointimal hyperplasia (NIH) in the coronary artery, the
impact of DES on NIH in the peripheral artery is unclear. This study
sought to investigate the difference of vascular response between
self-expanding bare-metal stent (BMS) and paclitaxel-eluting stent
(PES) for superﬁcial femoral artery (SFA) disease with optical fre-
quency domain imaging (OFDI).
METHODS Consecutive 40 de novo SFA lesions scheduled endovas-
cular therapy (EVT) were randomly assigned 1:1 to receive either BMS
(SMART) or PES (Zilver PTX) implantation. Follow-up angiography
and OFDI examination were conducted six months after EVT to
evaluate vascular response to the stent. Cross-sectional OFDI images
were analyzed at every 5-mm axial interval throughout stented seg-
ments, and stent and lumen borders were manually traced in all image
slices. Neointimal area was calculated as stent area - lumen area.
Stent, lumen, and neointimal volumes were calculated using Simp-
son’s rule. Percent neointimal volume obstruction was calculated as
neointimal volume divided by stent volume. Mean neointimal area
was as neointimal volume divided by stent length.
RESULTS Baseline patient and lesion characteristics were well-
matched between two groups. Total stent length was 96.529.1 mm in
the BMS group and 81.537.6 mm in the PES group (P¼0.17). Follow-
up angiography and OFDI were performed in 16 lesions of the BMS
group and in 16 lesions of the PES group. The binary angiographic ISR
rate was 25.0% in the BMS group and 6.2% in the PES group (P¼0.33).
Percent neointimal volume obstruction was lower in the PES group
compared to the BMS group (29.17.9% vs. 40.210.6%, P<0.01).
Mean neointimal area was smaller in the PES group (7.42.7 mm2 vs.
11.42.7 mm2, P<0.001).
Table. OFDI Findings at 6-month Follow-upBMS (n[16) PES (n[16) P valueNeointimal volume
(mm3)235.1  94.5 115.7  48.1 <0.001Mean neointimal area
(mm2)11.4  2.7 7.4  2.7 <0.001Minimum lumen area
(mm2)10.0  4.1 11.3  2.9 0.32%Neointimal volume
obstruction40.2  10.6 29.1  7.9 <0.01Data given as mean  SD or n (%)
BMS; bare-metal stent, PES; paclitaxel-eluting stent, OFDI; optical frequency domain imaging.
B322 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 5 , S U P P L B , 2 0 1 5CONCLUSIONS Volumetric OFDI analysis conﬁrmed signiﬁcantly less
NIH after PES implantation compared with BMS in the SFA. EVT with
DES decreases NIH that might associate with ISR.
CATEGORIES ENDOVASCULAR: Peripheral Vascular Disease and
Intervention
KEYWORDS Endovascular therapy, Imaging, Peripheral arterial dis-
easeTCT-792
Long Term Follow-up Meta-Analysis of Carotid Stenting Versus
Endarterectomy: Different Procedures with a Similar Safety Proﬁle
Alexandre M. Benjo,1 Yamini Ayakannu,2 Christopher White,2
Sayf Altabaqchali,2 Cody Williams,2 Georges EL-Hayek,3 Rajan Patel4
1Ochsner Medical Center / Pima Heart Cardiology, New Orleans, LA;
2Ochsner Medical Center, New Orleans, LA; 3St Luke’s Rosevelt
Hospital Center, New York, NY; 4Ochsner Medical Center, New Orleans,
United States
BACKGROUND Carotid stenting (CAS) and endarterectomy (CEA) are
strategies utilized to decrease the incidence of stroke among patients
with atherosclerotic carotid artery stenosis, especially for symptom-
atic patients. In the short term CAS has a higher incidence of minor
stroke while CEA has a higher incidence of cranial nerve palsy and
myocardial infarction. Long term data efﬁcacy data regarding these
strategies are now available.
METHODS We evaluated all randomized controlled trials (RCT’s)
comparing CEA and protected carotid stenting (CAS) with at least 12
months of follow-up to analyze the long term incidence of any stroke,
major stroke and death. Statistical analysis was performed with Rev-
man 5.3 software. When I2<25% ﬁxed effect analysis was used,
otherwise random effect analysis was used.
RESULTS The risk ratio for any stroke, major stroke and death were
similar. The results remained unchanged when the analysis was
limited to RCT’s including only symptomatic patients.CONCLUSIONS In this meta-analysis of RCT data, CAS and CEA have a
similar incidence of stroke and death during long term follow up.
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BACKGROUND In randomized controlled trials (RCTs) about 5% of
patients have signiﬁcant cranial nerve injury that affect their quality
of life scores following carotid endarterectomy (CEA). Recent data has
demonstrated that these deﬁcits persist over a month in 2/3 of the
patients and over a year in 1/5 of the patients. These injuries are at
least as disabling as a minor stroke. The epidemiology of cranial nerve
injuries from CEA is of interest to clinicians and their patients being
evaluated for CEA.
METHODS All RCTs comparing CEA and protected carotid stenting
(CAS) were evaluated to compare the short term incidence of major
stroke, total neurological deﬁcits including any stroke and cranial
nerve injury, myocardial infarct (MI) and death. We used Revman 5.3
software for statistical analysis. When I2<25% ﬁxed effect analysis
was used, otherwise random effect analysis was used.
RESULTS Major stroke and death were similar in both procedures but
total neurological deﬁcits and myocardial infarction were signiﬁcantly
more common in CEA. Speciﬁcally the risk ratio for any neurological
deﬁcits was 32% lower among CAS patients when compared to CEA
patients (Figure. RR 0.68 CI95% 0.50-0.92, p¼0.01).CONCLUSIONS RCTs data have demonstrated that, CEA and CAS are
similar with regard to the incidence of death or major stroke. How-
ever, CEA is more likely to result in neurological deﬁcits deﬁned as
stroke or cranial nerve injury.
